Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs
KPLC 7 News,
Xeltis, a clinical-stage medical device company pioneering a restorative approach in heart valve therapy, today announced the…